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Introduction
Preeclampsia (PE) is a heterogenic and multisystem 
pathologic condition appeared in pregnancy, characterized 
by hypertension and commonly accompanied with protein-
uria after 20 weeks of gestation. It is mediated by endothelial 
dysfunction, vasospasm and implication of one or more or-
gans inclusively utero-placentar system [1].
One of actual PE etiology theories is poor trophoblast 
invasion and improper spiral arteries remodeling, preceded 
by reduced utero-placentar perfusion, ischemia which is the 
principal cause of oxidative stress imbalance in favor of pro-
oxidants [2, 3]. The most important effect of pro- oxidants 
excess in PE is endothelial damage [4], vasospasm and in-
creased peripheral resistance [5]. 
Relevant to PE pro-oxidative factors are: Advanced Gly-
cation End Products, Advanced Oxidation Protein Prod-
ucts, Malondyaldehide, and Ischemic Modified Albumin. 
All of them are known to have a negative endothelial effect.
Advanced Glycation End Products bind to their receptor 
(RAGE) and alterate the invasion of trophoblast and pla-
centa, activating general inflammatory pathway and local 
inflammatory response being responsible for the placental 
dysfunction and IUGR in PE [6,7, 8].
Advanced oxidation protein products are considered a 
biomarker of oxidative stress known to be in excess in dif-
ferent metabolic syndromes and kidney diseases. It plays an 
important role in endothelial dysfunctions and proteinuria 
[9]. Also it’s suggested that AOPP are accumulated in pla-
centa and play a negative role in trophoblast invasion and 
increases apoptosis [10, 11]. 
Malondyaldehide is a result of lipid peroxidation which 
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Abstract
Background: The pathogenesis theories of preeclampsia include inappropriate trophoblast invasion and incomplete remodeling of spiral uterine arteries. 
This is followed by a reduced utero-placental perfusion; ischemia is the cause of oxidative stress activation. The imbalance between the oxidant and 
antioxidant components in favor of pro-oxidation, induce endothelium activation and / or dysfunction with the occurrence of clinical and laboratory 
manifestations.
Material and methods: It was proposed a comparative prospective study including 105 pregnant women with preeclampsia in comparison with 367 
pregnancies without preeclampsia. Pro-oxidant and antioxidant status and its correlation with systolic blood pressure values and classical laboratory 
marchers were analyzed.
Results: In preeclampsia there is an excess accumulation of pro-oxidants comparing to control group p<0.001. Malondialdehyde and Advanced Oxidation 
Protein Products are most implicated in hypertensive syndrome r 0.7, p<0.001. Inflammatory diseases of uro-excretory tract  accompanying preeclampsia, 
demonstrate excess accumulation of Advanced Oxidation Protein Products and AGE verprelizine-like and AGE pentozidine-like r 0.7, p<0.001. Modified 
ischemic albumin did not get the modified value in the research group.
Conclusions: Excess accumulation of pro-oxidants in preeclampsia plays an important role in pathogenesis pathway, clinical and laboratory manifestation 
of preeclampsia.
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results in oxidative stress. Lipid peroxides are considered 
to be toxic for endothelial cells, increase the synthesis of 
tromboxane with a decrease of prostacyclin synthesis with 
resulted vasoconstriction [12]. Excess of Malondyaldehide 
in PE is the cause of accumulation of reactive oxygen species 
and free radicals accumulation are involved in endothelial 
lesions [13].  So, all of pro-oxidants discussed manifesting 
endothelial injury and vasoconstriction are responsible for 
clinical and laboratory manifestations of PE as hypertensive 
syndrome, and proteinuria.
As antioxidant capacity are discussed Total Antioxidant 
Activity and Cupric Ionic Oxidation Capacity. The results 
of most studies indicate a decrease of antioxidant factors in 
PE [14, 15].
Material and methods
It was proposed a comparative prospective study which 
included sample research in 105 pregnant women with pre-
eclampsia and comparative sample in 367 pregnant women 
without preeclampsia. Including criteria in research sample 
were: singleton gestation with 27-41weeks gestation with 
preeclampsia. Excluding criteria were: multiple pregnan-
cies, diabetes, superimposed preeclampsia, congenital mal-
formations of the fetus and pregnancy with rhesus conflict. 
Including criteria for comparative sample were: singleton 
pregnancy without preeclampsia. Excluding criteria were: 
multiple pregnancy, diabetes, congenital malformations of 
the fetus and pregnancy with rhesus conflict.
The following pro-oxidant parameters were determined 
in our research: advanced oxidation protein products 
(AOPP), advanced glutathione end products verprelizine-
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like (AGE-Verpelizine-like) and advanced glutathione end 
products pentozidine-like (AGE-Pentozidine-like), Malo-
ndialdehyde (MDA). Antioxidant effect was studied based 
on total antioxidant capacity (TAC) and cupric ionic reduc-
ing capacity (CUPRAC).
The values of systolic blood pressure were measured 4 
times, every 6 hours daily. The results were introduced in 
data base ACCESS.
Results and discussion
First of all was studied the balance of oxidative stress in 
preeclampsia. As it is known, PE is a disease associated with 
an imbalance between pro-oxidant and antioxidant param-
eters of oxidative stress [15, 16, 17]. Comparative results of 
these parameters were set out in the table below:
Table 1
Average values of pro-oxidants and antioxidants of 
oxidative stress in the research and comparative groups 
(Media, SE, p)
Pro-oxidant/antioxidant factor Research sample
Control 
sample P
Advanced oxidation protein 
products
173.4±17.1 46.4±7.8 0
AGE verprelizine like 1209.5±201.5 349.9±26.3 0
AGE pentozidine like 2137.1±179.7 529.6±37.1 0
Malondialdehyde 34.5±4.0 18.3±2.2 0
Total antioxidant activity 8.8±16.7 8.1±10.6 0.9
Cupric ionic oxidation capacity 1.9±0.3 3.5±0.4 0.1
Ischemic modified albumine 0.4±0.1 0.4±0.1 0.3
As can be seen in the table, the mean values of pro-ox-
idant substances in PE are significantly different compared 
to these values in the control group. But the mean values of 
antioxidant substances are similar in both groups. Thus, we 
can deduce that PE is associated with an imbalance of oxi-
dative stress in favor of pro-oxidants at a concentration of 
antioxidants similar to the control group [15, 18]. Accord-
ing to Burton G.J. and other authors, pro-oxidants play a 
major role in pathophysiology of different pathologies in-
cluding PE. Because of superficial invasion of trophoblast 
and endothelium activation the placental barrier is broken, 
creating a leakage of pro-oxidants and placental debris in 
maternal circulation with activation of inflammatory cas-
cade and accumulation of more pro-oxidants. Accumulated 
pro-oxidants have a negative effect on maternal endothe-
lium being the most important cause of clinical manifesta-
tions of PE [19].
Malondialdehyde and Advanced Oxidation Protein 
Products are most relevant pro oxidants excess responsible 
for endothelial cell damage. MOA are the final products 
of lipids peroxidation. Activated endothelium in cerebral, 
renal and hepatic system decreases the synthesis of endo-
thelium derived vasodilatations such as Nitric Oxide and 
increases the synthesis of vasoconstrictors like Endothe-
liin1 and Tromboxane A2 which are responsible for vaso-
constriction and hypertensive manifestations of PE [20, 21].
Based on the above, we assumed the existence of correla-
tion between the higher values  of the pro-oxidant markers 
with first mandatory manifestation of preeclampsia- high 
values of systolic blood pressure which were measured 
before labor. As a result, we have achieved an intense and 
true correlation between these parameters and pro-oxidant 
markers of oxidative stress r 0.7, p <0.001 in the case of as-
sociation of the maximum blood pressure measured in the 
morning and r 0.5, p <0.001 to maximum values of systolic 
blood pressure at night and at midnight, and r 0.6, p <0.001 
at nocturnal systolic blood pressure. Furthermore, the high-
est values of systolic blood pressure were determined in the 
morning and in the night. 
The next step in our study was evaluation of correlation 
grade of pro-oxidants with biochemical parameters as total 
protein, urea, creatinine and fibrinogen blood levels which 
frequently are pathological in PE. 
Table 2
Representation of direct and indirect correlation  
between pro-oxidants parameters of oxidative  
stress and blood parameters in preeclampsia  
(correlation coefficient ”r”, p)
Pro-oxidant pa-
rameter
Biochemical 
parameter
Correla-
tion coef-
ficient ”r”
P
AGE pentozidine like Proteine in blood -0.4 <0.0001
AGE verprelizine like Ureia in blood 0.3 <0.0001
AOPP Fibrinogen 0.5 <0.0001
AOPP Creatinin in blood -0.3 <0.0001
MDA Proteine in blood 0.3 <0.0001
In terms of the results obtained and presented in the 
table above, there are various correlations between the 
pro-oxidant parameters and the biochemical parameters, 
which denote the systemic involvement of the pro-oxidant 
substances in the pathogenesis mechanisms of PE. As seen 
in the table above, there is obtained a negative correlation 
between AGE pentozidine-like marker and total amount of 
blood protein. With this was demonstrated that low con-
centration of general blood protein is dependent of high ac-
cumulation of AGE pentozidine-like which is known to be 
implicated in high permeability of endothelium and media-
tion of inflammation [22]. Another important correlation 
was found between AOPP and blood concentration of fi-
brinogen (r 0.5, p<0.0001) which is sugestive for association 
between inflammation and excessive acumulation of pro-
oxidants like AOPP. The next biochemical blood markers as 
ureia and creatinine demonstrated moderate but sure cor-
relation with AGE verprelizine-like and AOPP which also 
indicated a moderate implication of pro-oxidants in patho-
logical process of uroexcretor system.
One of frequent diagnostic criteria of PE is proteinuria. 
The following significant correlations were found between 
this criteria and pro-oxidants factors: AGE verprelizine-like 
and AGE pentozidine-like were in moderate correlation, 
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r 0.4, p <0.0001 and AOPP, MDA and proteinuria with r 
0.3, p <0.001. An interesting correlation has been found be-
tween the presence of bacteriuria in the urine investigation 
which was significantly correlated with AGE verprelizine-
like, AGE pentozidine-like and AOPP: r 0.7, p <0.0001 [23, 
24].  In support of the opinion that pro-oxidative factors are 
accumulating in excess in different independent pathologi-
cal conditions accompanying pregnancy with PE such as 
obesity, cardiovascular pathology, inflammatory disease of 
uro-excretor and genital system, the following significant 
correlations have been found. AOPP was mostly increased 
in pregnancy with PE and obesity, F 8.3, p<0.005 but in case 
of chronic pyelonephritis the values of AGE vertelizine-like 
and AGE pentozidine-like were significantly increased in 
the research group compared to their values in the control 
group, F 15.6,  p<0.0001. [25]. In case of cardiovascular and 
endocrine pathologies there were not found any significant 
correlations. Moreover, statistically significant correlations 
were found between vertelizine-like AGE concentrations in 
neo-natal outcome with ischemic brain lesions as compared 
to women in the research group without this result at birth 
χ2 17.6, p< 0.001[26, 27]. 
The last discussed pro-oxidant is Ischemic Modified Al-
bumin. There is a contradictory opinion about its role and 
importance in PE. Some of them consider it an important 
marker of ischemia while others did not find any correlation 
with PE in their studies [28, 29, 30]. In our study, no cor-
relation of IMA with clinical and/or laboratory parameters 
of PE was found.
Conclusions
Our study demonstrates the importance of oxidative 
stress imbalance in PE in favor of pro-oxidants p<0.0001. 
Most pro-oxidants implicated in PE have endothelial tox-
icity effect and promote inflammation mechanisms being 
responsible for vasoconstriction, hypoxia and hypertension. 
Inflammation of uro-excretory system (p<0.001) and obe-
sity are the most relevant medical conditions in PE with ex-
cess accumulation of pro-oxidants p<0.005. Also we found 
a moderate correlation between AGE verprelizine- like con-
centrations and fetal hypoxic brain lesions in PE. 
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